$ANAB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ANAPTYSBIO, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ANAPTYSBIO, INC. Get notifications about new insider transactions in ANAPTYSBIO, INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2021 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 10,000 | 11,200 | 30,361 | |
May 13 2021 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 10,000 | 11,200 | 30,361 | |
May 13 2021 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 10,000 | 11,200 | 57,636 | 47.6 K to 57.6 K (+20.99 %) |
May 13 2021 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 10,000 | 11,200 | 57,636 | 47.6 K to 57.6 K (+20.99 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.25 | 165,000 | 3,835,755 | 7,520,424 | 7.4 M to 7.5 M (+2.24 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.31 | 20,800 | 484,873 | 7,355,424 | 7.3 M to 7.4 M (+0.28 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.16 | 35,700 | 826,816 | 7,334,624 | 7.3 M to 7.3 M (+0.49 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.25 | 165,000 | 3,835,755 | 7,520,424 | 7.4 M to 7.5 M (+2.24 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.31 | 20,800 | 484,873 | 7,355,424 | 7.3 M to 7.4 M (+0.28 %) |
May 04 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.16 | 35,700 | 826,816 | 7,334,624 | 7.3 M to 7.3 M (+0.49 %) |
Apr 27 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.82 | 33,800 | 805,089 | 7,298,924 | 7.3 M to 7.3 M (+0.47 %) |
Apr 27 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.80 | 13,900 | 330,859 | 7,265,124 | 7.3 M to 7.3 M (+0.19 %) |
Apr 27 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | Director | Buy | P | 23.54 | 99,600 | 2,344,285 | 7,251,224 | 7.2 M to 7.3 M (+1.39 %) |
Mar 10 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | 10% Owner | Buy | P | 18.70 | 531,000 | 9,928,426 | 7,151,624 | 6.6 M to 7.2 M (+8.02 %) |
Mar 10 2021 | ANAB | ANAPTYSBIO, INC | EcoR1 Capital, LLC | 10% Owner | Buy | P | 18.97 | 2,777,800 | 52,694,310 | 6,620,624 | 3.8 M to 6.6 M (+72.29 %) |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Option Exercise | A | 29.70 | 119,700 | 3,555,090 | 119,700 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | LOUMEAU ERIC J | COO, General Counse ... | Option Exercise | M | 14.02 | 10,000 | 140,200 | 88,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | LOUMEAU ERIC J | COO, General Counse ... | Option Exercise | A | 29.70 | 45,000 | 1,336,500 | 45,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | LOUMEAU ERIC J | COO, General Counse ... | Sell | S | 35.00 | 10,000 | 350,000 | 0 | 10 K to 0 (-100.00 %) |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | LOUMEAU ERIC J | COO, General Counse ... | Buy | M | 14.02 | 10,000 | 140,200 | 10,000 | 0 to 10 K |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 29.70 | 45,000 | 1,336,500 | 45,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | FENTON DENNIS M | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Ware J. Anthony | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | RENTON HOLLINGS | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | RENTON HOLLINGS | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | A | 29.70 | 45,000 | 1,336,500 | 45,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | A | 29.70 | 45,000 | 1,336,500 | 45,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Marquet Magda | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Marquet Magda | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Feb 12 2021 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Option Exercise | A | 29.70 | 11,000 | 326,700 | 11,000 | |
Jan 19 2021 | ANAB | ANAPTYSBIO, INC | Marquet Magda | Director | Option Exercise | A | 26.11 | 784 | 20,470 | 784 | |
Jan 19 2021 | ANAB | ANAPTYSBIO, INC | Marquet Magda | Director | Option Exercise | A | 26.11 | 11,000 | 287,210 | 11,000 | |
Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Buy | J | 0.00 | 26,354 | 0 | 80,812 | 54.5 K to 80.8 K (+48.39 %) |
Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Buy | J | 0.00 | 22,604 | 0 | 54,458 | 31.9 K to 54.5 K (+70.96 %) |
Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Sell | J | 0.00 | 98,275 | 0 | 199,529 | 297.8 K to 199.5 K (-33.00 %) |
Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Sell | J | 0.00 | 344,860 | 0 | 700,171 | 1 M to 700.2 K (-33.00 %) |
Nov 18 2020 | ANAB | ANAPTYSBIO, INC | Topper James N | Director | Sell | J | 0.00 | 973,612 | 0 | 0 | 973.6 K to 0 (-100.00 %) |
Jul 31 2020 | ANAB | ANAPTYSBIO, INC | Lizzul Paul F. | Chief Medical Offic ... | Option Exercise | A | 18.50 | 90,000 | 1,665,000 | 90,000 | |
Jul 15 2020 | ANAB | ANAPTYSBIO, INC | LOUMEAU ERIC J | COO, General Counse ... | Option Exercise | A | 20.16 | 10,000 | 201,600 | 10,000 | |
Jul 15 2020 | ANAB | ANAPTYSBIO, INC | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 20.16 | 90,600 | 1,826,496 | 90,600 | |
Mar 10 2020 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 10,000 | 11,200 | 40,361 | |
Mar 10 2020 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 10,000 | 11,200 | 47,636 | 37.6 K to 47.6 K (+26.57 %) |
Feb 13 2020 | ANAB | ANAPTYSBIO, INC | Schmid John P. | Director | Option Exercise | A | 16.56 | 11,000 | 182,160 | 11,000 | |
Feb 13 2020 | ANAB | ANAPTYSBIO, INC | RENTON HOLLINGS | Director | Option Exercise | A | 16.56 | 11,000 | 182,160 | 11,000 | |
Feb 13 2020 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 16.56 | 11,000 | 182,160 | 11,000 | |
Feb 06 2020 | ANAB | ANAPTYSBIO, INC | Ware J. Anthony | Director | Buy | P | 14.05 | 3,600 | 50,580 | 3,600 | 0 to 3.6 K |
Feb 06 2020 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 10,000 | 11,200 | 50,361 | |
Feb 06 2020 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 10,000 | 11,200 | 37,636 | 27.6 K to 37.6 K (+36.18 %) |
Dec 17 2019 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Option Exercise | A | 15.73 | 280,000 | 4,404,400 | 280,000 | |
Dec 10 2019 | ANAB | ANAPTYSBIO, INC | LOUMEAU ERIC J | General Counsel & I ... | Option Exercise | A | 14.02 | 98,000 | 1,373,960 | 98,000 | |
Dec 10 2019 | ANAB | ANAPTYSBIO, INC | Londei Marco | Chief Medical Offic ... | Option Exercise | A | 14.02 | 98,000 | 1,373,960 | 98,000 | |
Dec 02 2019 | ANAB | ANAPTYSBIO, INC | Londei Marco | Chief Medical Offic ... | Option Exercise | M | 6.93 | 46,202 | 320,180 | 4,946 | |
Dec 02 2019 | ANAB | ANAPTYSBIO, INC | Londei Marco | Chief Medical Offic ... | Buy | M | 6.93 | 46,202 | 320,180 | 68,579 | 22.4 K to 68.6 K (+206.47 %) |
Nov 25 2019 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 10,000 | 11,200 | 60,361 | |
Nov 25 2019 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 10,000 | 11,200 | 60,361 | |
Nov 25 2019 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 10,000 | 11,200 | 27,636 | 17.6 K to 27.6 K (+56.70 %) |
Nov 25 2019 | ANAB | ANAPTYSBIO, INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 10,000 | 11,200 | 27,636 | 17.6 K to 27.6 K (+56.70 %) |
Sep 26 2019 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 38.47 | 2,268 | 87,250 | 2,268 | |
Sep 26 2019 | ANAB | ANAPTYSBIO, INC | Hamill Laura | Director | Option Exercise | A | 38.47 | 6,000 | 230,820 | 6,000 | |
Aug 20 2019 | ANAB | ANAPTYSBIO, INC | LOUMEAU ERIC J | General Counsel & I ... | Option Exercise | A | 49.20 | 17,500 | 861,000 | 17,500 | |
Jun 12 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 76.31 | 454 | 34,645 | 17,636 | 18.1 K to 17.6 K (-2.51 %) |
Jun 12 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 75.86 | 1,994 | 151,271 | 18,090 | 20.1 K to 18.1 K (-9.93 %) |
Jun 12 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 74.68 | 5,000 | 373,413 | 20,084 | 25.1 K to 20.1 K (-19.93 %) |
Jun 12 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 73.70 | 6,440 | 474,637 | 25,084 | 31.5 K to 25.1 K (-20.43 %) |
Jun 12 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 72.64 | 8,540 | 620,385 | 31,524 | 40.1 K to 31.5 K (-21.32 %) |
Jun 05 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | M | 0.70 | 10,060 | 7,042 | 0 | |
Jun 05 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 74.50 | 2,003 | 149,219 | 22,377 | 24.4 K to 22.4 K (-8.22 %) |
Jun 05 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 73.43 | 2,048 | 150,384 | 24,380 | 26.4 K to 24.4 K (-7.75 %) |
Jun 05 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 72.45 | 6,009 | 435,359 | 26,428 | 32.4 K to 26.4 K (-18.53 %) |
Jun 05 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Buy | M | 0.70 | 10,060 | 7,042 | 32,437 | 22.4 K to 32.4 K (+44.96 %) |
Apr 18 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 10,000 | 11,200 | 70,361 | |
Apr 18 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 10,000 | 11,200 | 40,064 | 30.1 K to 40.1 K (+33.26 %) |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Ware J. Anthony | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Topper James N | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | A | 68.89 | 94,000 | 6,475,660 | 94,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Schmid John P. | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | RENTON HOLLINGS | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Option Exercise | A | 68.89 | 35,000 | 2,411,150 | 35,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Lydon Nicholas | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | LOUMEAU ERIC J | General Counsel | Option Exercise | A | 68.89 | 35,000 | 2,411,150 | 35,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | A | 68.89 | 35,000 | 2,411,150 | 35,000 | |
Feb 11 2019 | ANAB | ANAPTYSBIO INC | FENTON DENNIS M | Director | Option Exercise | A | 68.89 | 6,000 | 413,340 | 6,000 | |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 40,000 | 44,800 | 89,284 | |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 71.10 | 12,240 | 870,304 | 30,064 | 42.3 K to 30.1 K (-28.93 %) |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 70.65 | 27,760 | 1,961,227 | 42,304 | 70.1 K to 42.3 K (-39.62 %) |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 40,000 | 44,800 | 70,064 | 30.1 K to 70.1 K (+133.05 %) |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | M | 6.93 | 19,075 | 132,190 | 51,148 | |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 70.04 | 14,894 | 1,043,195 | 22,377 | 37.3 K to 22.4 K (-39.96 %) |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 69.29 | 4,181 | 289,686 | 37,271 | 41.5 K to 37.3 K (-10.09 %) |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Buy | M | 6.93 | 19,075 | 132,190 | 41,452 | 22.4 K to 41.5 K (+85.24 %) |
Jan 16 2019 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Gift | G | 0.00 | 122,500 | 0 | 22,377 | 144.9 K to 22.4 K (-84.55 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | M | 6.93 | 22,000 | 152,460 | 70,223 | |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | M | 6.93 | 22,000 | 152,460 | 70,223 | |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | M | 0.70 | 8,048 | 5,634 | 10,060 | |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | M | 0.70 | 8,048 | 5,634 | 10,060 | |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 68.47 | 6,741 | 461,578 | 144,877 | 151.6 K to 144.9 K (-4.45 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 68.47 | 6,741 | 461,578 | 144,877 | 151.6 K to 144.9 K (-4.45 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 67.57 | 8,002 | 540,684 | 151,618 | 159.6 K to 151.6 K (-5.01 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 67.57 | 8,002 | 540,684 | 151,618 | 159.6 K to 151.6 K (-5.01 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 66.38 | 3,185 | 211,416 | 159,620 | 162.8 K to 159.6 K (-1.96 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 66.38 | 3,185 | 211,416 | 159,620 | 162.8 K to 159.6 K (-1.96 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 65.36 | 12,120 | 792,178 | 162,805 | 174.9 K to 162.8 K (-6.93 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Sell | S | 65.36 | 12,120 | 792,178 | 162,805 | 174.9 K to 162.8 K (-6.93 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Buy | M | 6.93 | 22,000 | 152,460 | 174,925 | 152.9 K to 174.9 K (+14.39 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Buy | M | 6.93 | 22,000 | 152,460 | 174,925 | 152.9 K to 174.9 K (+14.39 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Buy | M | 0.70 | 8,048 | 5,634 | 152,925 | 144.9 K to 152.9 K (+5.56 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Buy | M | 0.70 | 8,048 | 5,634 | 152,925 | 144.9 K to 152.9 K (+5.56 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 41,728 | 46,735 | 129,284 | |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 41,728 | 46,735 | 129,284 | |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 70.51 | 7,800 | 549,979 | 30,064 | 37.9 K to 30.1 K (-20.60 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 70.51 | 7,800 | 549,979 | 30,064 | 37.9 K to 30.1 K (-20.60 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 69.68 | 9,084 | 632,968 | 37,864 | 46.9 K to 37.9 K (-19.35 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 69.68 | 9,084 | 632,968 | 37,864 | 46.9 K to 37.9 K (-19.35 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 68.89 | 24,844 | 1,711,429 | 46,948 | 71.8 K to 46.9 K (-34.61 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 68.89 | 24,844 | 1,711,429 | 46,948 | 71.8 K to 46.9 K (-34.61 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 41,728 | 46,735 | 71,792 | 30.1 K to 71.8 K (+138.80 %) |
Dec 18 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 41,728 | 46,735 | 71,792 | 30.1 K to 71.8 K (+138.80 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 30,000 | 33,600 | 80,361 | |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 1.12 | 30,587 | 34,257 | 110,361 | |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 72.88 | 8,324 | 606,618 | 30,064 | 38.4 K to 30.1 K (-21.68 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 71.92 | 9,673 | 695,718 | 38,388 | 48.1 K to 38.4 K (-20.13 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 71.11 | 12,003 | 853,481 | 48,061 | 60.1 K to 48.1 K (-19.98 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 30,000 | 33,600 | 60,064 | 30.1 K to 60.1 K (+99.79 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 70.83 | 4,998 | 354,008 | 30,064 | 35.1 K to 30.1 K (-14.25 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 72.48 | 4,964 | 359,805 | 35,062 | 40 K to 35.1 K (-12.40 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 71.49 | 10,347 | 739,701 | 40,026 | 50.4 K to 40 K (-20.54 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Sell | S | 70.57 | 15,276 | 1,078,082 | 50,373 | 65.6 K to 50.4 K (-23.27 %) |
Dec 12 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 1.12 | 30,587 | 34,257 | 65,649 | 35.1 K to 65.6 K (+87.24 %) |
Dec 04 2018 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Option Exercise | M | 11.34 | 37,000 | 419,580 | 133,241 | |
Dec 04 2018 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Sell | S | 75.81 | 1,100 | 83,390 | 0 | 1.1 K to 0 (-100.00 %) |
Dec 04 2018 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Sell | S | 74.33 | 6,624 | 492,362 | 1,100 | 7.7 K to 1.1 K (-85.76 %) |
Dec 04 2018 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Sell | S | 73.18 | 2,298 | 168,159 | 7,724 | 10 K to 7.7 K (-22.93 %) |
Dec 04 2018 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Sell | S | 72.24 | 4,820 | 348,212 | 10,022 | 14.8 K to 10 K (-32.48 %) |
Dec 04 2018 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Sell | S | 71.33 | 18,604 | 1,327,061 | 14,842 | 33.4 K to 14.8 K (-55.62 %) |
Dec 04 2018 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Sell | S | 70.34 | 3,554 | 249,974 | 33,446 | 37 K to 33.4 K (-9.61 %) |
Dec 04 2018 | ANAB | ANAPTYSBIO INC | Piscitelli Dominic | Chief Financial Off ... | Buy | M | 11.34 | 37,000 | 419,580 | 37,000 | 0 to 37 K |
Sep 10 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Option Exercise | M | 0.70 | 142,857 | 100,000 | 18,108 | |
Sep 10 2018 | ANAB | ANAPTYSBIO INC | Londei Marco | Chief Medical Offic ... | Buy | M | 0.70 | 142,857 | 100,000 | 144,877 | 2 K to 144.9 K (+7,072.13 %) |
Aug 08 2018 | ANAB | ANAPTYSBIO INC | LOUMEAU ERIC J | General Counsel | Option Exercise | A | 78.18 | 40,000 | 3,127,200 | 40,000 | |
Jul 11 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 1.61 | 6,208 | 9,995 | 0 | |
Jul 11 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 2.24 | 1,428 | 3,199 | 0 | |
Jul 11 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 1.61 | 6,208 | 9,995 | 35,062 | 28.9 K to 35.1 K (+21.52 %) |
Jul 11 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 2.24 | 1,428 | 3,199 | 28,854 | 27.4 K to 28.9 K (+5.21 %) |
Jun 11 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Option Exercise | M | 2.59 | 22,428 | 58,089 | 0 | |
Jun 11 2018 | ANAB | ANAPTYSBIO INC | Suria Hamza | President, CEO | Buy | M | 2.59 | 22,428 | 58,089 | 27,426 | 5 K to 27.4 K (+448.74 %) |